Business Context and Reporting Period
This Form 6-K filing by Scinai Immunotherapeutics Ltd. covers the month of May 2026. The report serves to notify shareholders of an upcoming Annual Meeting of Shareholders scheduled for June 16, 2026, at 4:00 p.m. Israel time in Tel Aviv, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document focuses solely on the administrative details of the shareholder meeting.
Guidance, Outlook, and Management Commentary
The filing includes no guidance, outlook, or management commentary regarding future business prospects. It details the submission of the Notice and Proxy Statement (Exhibit 99.1) and the Proxy Card (Exhibit 99.2) for the Annual Meeting. The report is incorporated by reference into the company's Registration Statements on Form S-8 and Form F-3.
Key Facts for Investor Verification
- Meeting Date: Tuesday, June 16, 2026.
- Meeting Time: 4:00 p.m. Israel time.
- Location: Offices of Goldfarb Gross Seligman & Co., One Azrieli Center, Round Tower, Tel Aviv, Israel.
- Voting Materials: Notice and Proxy Statement and Proxy Card are available as Exhibits 99.1 and 99.2.
- Signatory: Amir Reichman, Chief Executive Officer, signed on May 12, 2026.